Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karolina Kauppi

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Pharmacoepidemiology and Drug Safety|November 10, 2022
Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioningElise Koch, Kristina Johnell, Karolina Kauppi
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 13, 2022
Candidates for drug repurposing to address the cognitive symptoms in schizophreniaElise Koch, Karolina Kauppi, Chi-Hua Chen
Genes|March 25, 2022
Polygenic Risk for Schizophrenia Has Sex-Specific Effects on Brain Activity during Memory Processing in Healthy IndividualsElise Koch, Lars Nyberg, Anders Lundquist, et al.
Neuroimage|December 11, 2013
Additive genetic effect of APOE and BDNF on hippocampus activityKarolina Kauppi, Lars-Göran Nilsson, Jonas Persson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 7, 2011
KIBRA polymorphism is related to enhanced memory and elevated hippocampal processingKarolina Kauppi, Lars-Göran Nilsson, Rolf Adolfsson, et al.
Translational Psychiatry|July 26, 2020
Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal agingKarolina Kauppi, Michael Rönnlund, Annelie Nordin Adolfsson, et al.
Scientific Reports|May 24, 2023
APOE ɛ4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individualsSofia Håglin, Elise Koch, Fernanda Schäfer Hackenhaar, et al.
Schizophrenia Research|June 18, 2020
Interactome overlap between schizophrenia and cognitionElise Koch, Brin Rosenthal, Anders Lundquist, et al.
Neurobiology of Aging|March 25, 2023
Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in agingAdil Supiyev, Robert Karlsson, Yunzhang Wang, et al.
Translational Psychiatry|October 12, 2021
Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individualsElise Koch, Lars Nyberg, Anders Lundquist, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Pharmacoepidemiology and Drug Safety|November 10, 2022
Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioningElise Koch, Kristina Johnell, Karolina Kauppi
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 13, 2022
Candidates for drug repurposing to address the cognitive symptoms in schizophreniaElise Koch, Karolina Kauppi, Chi-Hua Chen
Genes|March 25, 2022
Polygenic Risk for Schizophrenia Has Sex-Specific Effects on Brain Activity during Memory Processing in Healthy IndividualsElise Koch, Lars Nyberg, Anders Lundquist, et al.
Neuroimage|December 11, 2013
Additive genetic effect of APOE and BDNF on hippocampus activityKarolina Kauppi, Lars-Göran Nilsson, Jonas Persson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 7, 2011
KIBRA polymorphism is related to enhanced memory and elevated hippocampal processingKarolina Kauppi, Lars-Göran Nilsson, Rolf Adolfsson, et al.
Translational Psychiatry|July 26, 2020
Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal agingKarolina Kauppi, Michael Rönnlund, Annelie Nordin Adolfsson, et al.
Scientific Reports|May 24, 2023
APOE ɛ4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individualsSofia Håglin, Elise Koch, Fernanda Schäfer Hackenhaar, et al.
Schizophrenia Research|June 18, 2020
Interactome overlap between schizophrenia and cognitionElise Koch, Brin Rosenthal, Anders Lundquist, et al.
Neurobiology of Aging|March 25, 2023
Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in agingAdil Supiyev, Robert Karlsson, Yunzhang Wang, et al.
Translational Psychiatry|October 12, 2021
Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individualsElise Koch, Lars Nyberg, Anders Lundquist, et al.
Pageof 4